3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoic acid

Metabolite details

Identifier

HEXMLHKQVUFYME-UHFFFAOYSA-N

InChI Key

HEXMLHKQVUFYME-UHFFFAOYSA-N

IUPAC name

3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoic acid

Preferred name

3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoic acid

INN name

—

Synonym

4-Imidazolone-5-propionic acid

ChEBI

CHEBI:27384

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• WT_vs_WT_Aco
• Control_vs_Lithogenic_Diet
• Control_vs_Exercise